Yes. Tapentadol is one of the 76 compounds in the LabX LC-MS/MS confirmation panel, reported as detected at or above 50 ng/mL. Tapentadol is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Tapentadol is a synthetic pain medicine that acts on opioid receptors and blocks the reuptake of norepinephrine. It is a federally controlled (Schedule II) substance.
Also known as or found in: Nucynta.
Tapentadol is prescribed for acute pain and, in an extended-release form, for certain chronic pain conditions including diabetic nerve pain.
Tapentadol is measured by liquid chromatography with tandem mass spectrometry (LC-MS/MS), which separates the compounds in a sample and identifies each one by its mass. That is different from a rapid screen, which reacts to a family of drugs and can occasionally react to a related substance. The laboratory reports Tapentadol as detected when its concentration is at or above the cut-off of 50 ng/mL, within a reportable range of 50–5,000 ng/mL. It is one of 16 compounds in the opioids and their metabolites family on the 76-drug confirmation panel.
The laboratory's confirmation report lists an approximate detection window of 1-3 days for Tapentadol. Treat that as a rough guide only: how long any compound stays measurable varies with the amount taken, how often it is used, body composition, metabolism, kidney and liver function, and hydration. A laboratory result cannot be used to work out when a substance was taken.
Tapentadol is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Tapentadol is not picked up by standard opiate screens. Our LC-MS/MS confirmation measures both tapentadol and its metabolite N-desmethyltapentadol.
Prescription opioid pain medicines, heroin markers and the compounds the body makes from them. Measuring metabolites alongside parent drugs shows a drug was actually processed by the body.
Yes. Tapentadol is one of the 76 compounds in the LabX LC-MS/MS confirmation panel, reported as detected at or above 50 ng/mL. Tapentadol is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
LabX reports Tapentadol as detected at or above 50 ng/mL, and the method's reportable range is 50–5,000 ng/mL. A result below the cut-off is reported as not detected; it does not prove none was present.
The laboratory lists an approximate window of 1-3 days, but it varies with dose, frequency of use, metabolism and hydration, and cannot be used to tell when something was taken.
Tapentadol is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Tapentadol is prescribed for acute pain and, in an extended-release form, for certain chronic pain conditions including diabetic nerve pain.
Terms on this page: metabolite · cut-off · detection window · presumptive result · confirmation test. More questions: LabX answers.
Test for Tapentadol and 75 other compounds
12-panel urine $89 or fingerstick blood $99, plus the 76-drug LC-MS/MS confirmation for +$89.
At-home drug tests and test kits are not currently available to addresses in New York, New Jersey, Rhode Island or California. Results are not a diagnosis — review them with a licensed physician.
Medical disclaimer. LabX Diagnostics and Vantage provide laboratory testing only. Test results and information on this site are for informational purposes and are not medical advice, diagnosis or treatment. Always consult a licensed physician or other qualified healthcare provider about your results and before making any health decision. If you think you may have a medical emergency, call 911. Read the full disclaimer.
Learn: 76-drug confirmation list · Drug library · Answers · How it works · Is LabX legit? · Glossary
